Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Jul 31, 2024 | (FY)Jul 31, 2023 | (FY)Jul 31, 2022 | (FY)Jul 31, 2021 | (FY)Jul 31, 2020 | (FY)Jul 31, 2019 | (FY)Jul 31, 2018 | (FY)Jul 31, 2017 | (FY)Jul 31, 2016 | (FY)Jul 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 18.51%1.6B | -13.45%1.35B | 107.76%1.56B | -31.30%751M | -6.67%1.09B | 71.43%1.17B | 28.31%683.22M | 16.83%532.48M | 30.72%455.78M | 348.66M |
Net profit before non-cash adjustment | 11.60%955.92M | 38.69%856.53M | -28.73%617.6M | -18.84%866.51M | 7.55%1.07B | 49.04%992.78M | 27.07%666.12M | 23.42%524.23M | 37.12%424.74M | --309.75M |
Total adjustment of non-cash items | 16.48%809.62M | -1.33%695.05M | 84.75%704.43M | 128.85%381.29M | 35.80%166.61M | 15.40%122.69M | 154.03%106.32M | -46.60%41.85M | 28.61%78.38M | --60.94M |
-Depreciation and amortization | 15.68%797.87M | 13.04%689.73M | 81.44%610.15M | 98.62%336.29M | 15.69%169.31M | 29.05%146.35M | 35.67%113.4M | 3.92%83.59M | 33.62%80.43M | --60.19M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | 27.75%95.48M | --74.74M | ---- | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | 590.00%9.11M | 136.43%1.32M | -111.36%-3.62M | 72.25%31.88M | 95.43%18.51M | -17.24%9.47M | -24.63%11.44M | 53.61%15.18M | 61.97%9.89M | --6.1M |
-Other non-cash items | -33.87%2.65M | 65.25%4M | 103.93%2.42M | -190.56%-61.62M | 35.98%-21.21M | -78.82%-33.13M | 67.45%-18.53M | -376.81%-56.92M | -123.00%-11.94M | ---5.35M |
Changes in working capital | 17.93%-165.03M | -184.39%-201.09M | 147.96%238.28M | -251.85%-496.79M | -353.05%-141.19M | 162.54%55.8M | -165.48%-89.21M | 29.01%-33.61M | -114.86%-47.34M | ---22.03M |
-Change in receivables | -31.84%-158.01M | -133.05%-119.85M | 47.15%-51.42M | 22.52%-97.31M | -26.02%-125.6M | 8.61%-99.67M | -0.77%-109.06M | -49.71%-108.23M | -5.97%-72.29M | ---68.22M |
-Change in inventory | 57.32%-64.08M | -32.73%-150.11M | 8.81%-113.09M | -378.69%-124.02M | -788.82%-25.91M | 77.32%-2.92M | -122.12%-12.85M | 63.26%-5.79M | -90.76%-15.75M | ---8.26M |
-Change in payables | 8.00%68.78M | -82.23%63.68M | 212.78%358.38M | -4,541.27%-317.77M | -95.59%7.16M | 458.75%162.16M | -58.01%29.02M | 91.64%69.11M | -11.53%36.06M | --40.76M |
-Provision for loans, leases and other losses | -110.20%-1.65M | -68.03%16.16M | 19.48%50.56M | 1,238.63%42.31M | 183.62%3.16M | -202.72%-3.78M | -67.42%3.68M | 143.61%11.3M | -66.10%4.64M | --13.68M |
-Changes in other current assets | 8.11%-10.08M | -78.65%-10.97M | ---6.14M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -10.48%-4.86M | 13.08%-4.4M | -164.61%-5.06M | -1.91M | 95.77%-21K | 62.14%-496K | 45.78%-1.31M | 40.71%-2.42M | -4.08M | |
Interest received (cash flow from operating activities) | -9.13%11.68M | 4.04%12.85M | 15.10%12.35M | 9.87%10.73M | 22.79%9.77M | 21.73%7.96M | 39.18%6.54M | 18.32%4.7M | 24.19%3.97M | 3.2M |
Tax refund paid | -85.42%-292.07M | 55.97%-157.52M | 8.38%-357.71M | 7.92%-390.42M | -55.52%-424M | -49.36%-272.64M | -66.68%-182.54M | 39.67%-109.52M | -1,097.63%-181.55M | -15.16M |
Other operating cash inflow (outflow) | 0.00%-1K | -1K | 0 | 0 | 0 | -1K | 0 | 0 | 0 | -1K |
Operating cash flow | 9.47%1.32B | -0.70%1.2B | 227.53%1.21B | -45.59%369.4M | -25.12%678.88M | 78.91%906.57M | 18.85%506.72M | 54.59%426.35M | -17.09%275.79M | --332.62M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -36.42%-1.07B | 41.85%-787.43M | 47.40%-1.35B | -170.60%-2.57B | -236.61%-951.45M | 59.12%-282.66M | -260.34%-691.45M | -34.62%-191.89M | -32.44%-142.54M | ---107.63M |
Net intangibles purchase and sale | 48.13%-88.9M | -42.20%-171.39M | 2.09%-120.53M | 17.72%-123.1M | -188.12%-149.61M | -8.00%-51.93M | -60.82%-48.08M | -52.40%-29.89M | -223.96%-19.62M | ---6.06M |
Net investment product transactions | -4.81%-5.93M | 3.81%-5.66M | -0.60%-5.88M | 0.29%-5.84M | 66.52%-5.86M | -209.58%-17.51M | -1,100.64%-5.66M | 91.49%-471K | ---5.53M | ---- |
Advance cash and loans provided to other parties | 57.80%-3.62M | 46.41%-8.57M | 55.26%-16M | -60.32%-35.76M | -82.72%-22.31M | -36.90%-12.21M | 39.44%-8.92M | -55.63%-14.72M | 42.54%-9.46M | ---16.47M |
Repayment of advance payments to other parties and cash income from loans | -1.52%12.39M | -13.21%12.58M | -9.57%14.5M | 31.49%16.03M | -21.15%12.19M | -14.08%15.46M | 32.79%17.99M | 2.68%13.55M | -35.15%13.2M | --20.35M |
Net changes in other investments | -86.07%3.15M | 102.36%22.59M | -67.14%11.16M | 101.66%33.97M | -32.05%16.85M | 22.52%24.8M | 22.19%20.24M | 58.60%16.56M | -26.13%10.44M | --14.14M |
Investing cash flow | -23.38%-1.16B | 36.24%-937.87M | 45.30%-1.47B | -144.44%-2.69B | -239.52%-1.1B | 54.73%-324.04M | -246.05%-715.87M | -34.76%-206.87M | -60.47%-153.51M | ---95.66M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 0.00%-239.4M | -191.86%-239.4M | -86.50%260.6M | --1.93B | ---- | 87.54%-25.3M | -3,134.08%-202.98M | 108.57%6.69M | 25.09%-78.08M | ---104.24M |
Net common stock issuance | -76.17%2.2M | 206.53%9.25M | -80.95%3.02M | 45.32%15.83M | -36.76%10.89M | -98.75%17.23M | --1.38B | ---- | ---- | --990K |
Increase or decrease of lease financing | 0.00%-720K | -500.00%-720K | 86.58%-120K | 68.78%-894K | -135.53%-2.86M | 0.00%-1.22M | -7.99%-1.22M | -49.93%-1.13M | ---751K | ---- |
Cash dividends paid | ---162.64M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net other fund-raising expenses | 0.00%-1K | 0.00%-1K | 0.00%-1K | 0.00%-1K | 0.00%-1K | 99.99%-1K | -998,300.00%-9.98M | ---1K | ---- | ---- |
Financing cash flow | -73.49%-400.55M | -187.62%-230.88M | -86.45%263.5M | 24,127.00%1.95B | 186.43%8.03M | -100.80%-9.29M | 20,900.07%1.17B | 107.06%5.56M | 23.65%-78.83M | ---103.25M |
Net cash flow | ||||||||||
Beginning cash position | 2.22%1.51B | 0.16%1.47B | -20.29%1.47B | -18.28%1.85B | 33.97%2.26B | 131.71%1.69B | 44.73%728.16M | 9.45%503.11M | 41.02%459.67M | --325.96M |
Current changes in cash | -841.86%-242.43M | 1,258.79%32.68M | 100.64%2.41M | 9.32%-374.75M | -172.10%-413.28M | -40.23%573.23M | 326.18%959.08M | 418.04%225.04M | -67.51%43.44M | --133.71M |
Cash adjustments other than cash changes | ---- | 0.00%1K | --1K | ---- | ---- | ---- | --1K | ---- | ---- | ---1K |
End cash Position | -16.08%1.27B | 2.22%1.51B | 0.16%1.47B | -20.29%1.47B | -18.28%1.85B | 33.97%2.26B | 131.71%1.69B | 44.73%728.16M | 9.45%503.11M | --459.67M |
Free cash flow | -37.29%152.13M | 173.54%242.61M | 85.87%-329.89M | -445.42%-2.33B | -175.04%-427.91M | 343.89%570.28M | -214.61%-233.83M | 83.59%204.02M | -49.06%111.13M | --218.17M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |